It’s almost here!

 In September 2022 OvaryIt was Awarded a Phase 1 feasibility study. The results were published in the Journal of the American Medical Informatics Association Open: Phase 1 Publication

Shortly after, in March 2023 OvaryIt was invited to participate in the NIH “incubator” program, I-Corps. There we completed nearly 150 interviews with pharmacists, pharmacy owners, and industry leaders to ensure feasibility and product market fit.

 In August 2024, OvaryIt was awarded a Phase 2 NIH grant to commercialize a platform empowering pharmacists to prescribe contraception. This clinical trial is an integral part of the ongoing Phase 2 initiative. 

This study is a 12-week pilot program conducted at select pharmacies across the United States. Participating pharmacists will use the PRISM software platform to deliver contraceptive services directly in a community pharmacy setting. The platform is intended to streamline workflows and provide clinical decision support to facilitate pharmacist-led care. Your participation will not only give patients in your community convenient access to contraceptive services but will also generate valuable real-world data on the feasibility of implementing these services using the PRISM platform. Furthermore, the insights gained from this study may help fill a critical gap in the literature regarding pharmacist-led contraceptive care, potentially informing strategies to broaden adoption nationwide, which could enhance patient access and support future efforts to expand pharmacists’ scope of practice. 

Applicants in the following states will be given preference: California, Illinois, Minnesota, South Carolina, and Utah. 

 There are many benefits to join the study:

• Financial Support: Participating pharmacies will receive reimbursement of $50 per contraceptive encounter (up to 25 encounters) plus a $3,000 local outreach budget for patient recruitment.
• PRISM Subscription: A complimentary 1-year subscription to PRISM (Pharmacist Resource for Implementing Services as Modules), our EHR designed specifically for pharmacy-based clinical services, supporting service continuation beyond the trial.
• Pharmacist & Staff Benefits: The study covers the cost of a contraceptive educational course, which offers 0.4 CEUs to each participating pharmacist. Staff who participate will be compensated with gift cards for completing a study orientation and surveys (up to $350 for pharmacists and $75 for pharmacy technicians/support staff).
• Patient Incentives: Complimentary contraceptive services and up to $50 in gift cards for completing surveys.

1. Review information throughout this page.
2. Use the meeting links at the top and bottom of the page to schedule a conversation with the study team
3. Complete the Pharmacy Enrollment Application that will be provided after the conversation